William "Bill" F. Haning, III, M.D., FASAM, DFAPA Professor, Department of Psychiatry John A. Burns School of Medicine, Director of Graduate Affairs Program Director, Addiction Psychiatry/Addiction Medicine EDUCATIONAL SUMMARY John A. Burns School of Medicine, University of Hawaii - M.D., 1975 National Naval Medical Center, Bethesda, Maryland - Internship, 1976 University of Hawaii Affiliated Hospitals - Residency Psychiatry, 1995 RELEVANT PRIOR EXPERIENCE Hawaii Institute for Chemical Dependency and Stress, 1985 - 1987 Medical Director, Tri-Service Alcoholism Recovery Facility, Tripler Army Medical Center (HI), 1988 - 1992 Director, Addiction Psychiatry, Hawaii State Hospital, 1996 - 2000 Director, Addiction Psychiatry Program, John A. Burns School of Medicine, University of Hawaii, Department of Psychiatry, 1996 – present; Addiction Psychiatry Residency Program, 1998 - present Medical Director, Hina Mauka (Alcoholic Treatment Services of Hawaii, Inc.), 1995 – present Associate Professor of Psychiatry, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 1996 – present Medical Director, Inpatient Psychiatry 1997 – 2000 & Assistant Chief of Psychiatry, The Queen’s Medical Center, 1997-2003 Co-Director and Executive, Pacific Addiction Research Center, Department of Psychiatry, John A. Burns School of Medicine Associate Dean for Graduate Affairs & Faculty Development, John A. Burns School of Medicine, 2000 - present RESPONSIBILITIES/ACTIVITIES IN THIS RESIDENCY Direction of residency program, instruction and supervision of residents to include lectures, symposia, and colloquia; curriculum development; direct liaison with the inpatient psychiatric services of the Queen’s Medical Center, Tripler Army Medical Center and the Department of Veterans’ Affairs Spark M. Matsunaga Veterans’ Medical Center, Hina Mauka Alcoholism Recovery Facility, DASH, and the Adult Mental Health Division of the Department of Health of the State of Hawaii; representation to the Executive, Evaluation, and Training committees of the Department of Psychiatry, JABSOM. RESEARCH/SCHOLARLY INTERESTS Substance use disorders in-patients with concomitant HIV neuropsychopathology; amphetamine use epidemiology and pathophysiology; alcohol and drug use disorders in health care professionals. Ongoing Research Support N01 DA-0-8804 (PI: Haning, W.) 9/1/2001-5/31/2002 NIDA/NIH Behavioral Trial for the Treatment of Methamphetamine Dependence To characterize methamphetamine withdrawal symptoms using a questionnaire that includes physical, functional, and self report measures; to field test an algorithm developed for discriminating between new use and residual carry-over of methamphetamine metabolites in urine samples; and to establish a baseline treatment response for methamphetamine users for a manualized behavioral treatment protocol that will serve as a platform for future pharmacotherapy trials. N01 DA-0-8804 (PI: Haning, W.) 4/1/2002-4/30/2003 NIDA/NIH Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence To conduct a preliminary assessment of the efficacy and safety of three wide range doses of ondansetron to reduce methamphetamine use in 180 subjects with methamphetamine dependence and to determine the optimal dose of ondansetron. N01 DA-0-8804 (PI: Haning, W.) 9/1/2003-4/30/2004 NIDA/NIH Double-Blind, Placebo-Controlled, Trial of Bupropion for the Treatment of Methamphetamine Dependence To conduct a preliminary assessment of the efficacy and safety of a single dose of bupropion to reduce methamphetamine use in 150 subjects with methamphetamine dependence. RFA DA-01-005 (P.I.: Lester, Barry, Brown University; DeRauf, C. University of Hawaii; Co-PI: Haning, W. University of Hawaii) 11/15/2001 – 11/14/2006 Brown University/NIDA Prenatal Methamphetamine Exposure and Child Development To assess developmental impact of intrauterine exposure to methamphetamine in 200 infant subjects recruited at birth, multi-site study. PUBLICATIONS McDermott JF, Haning WF et al.: Interviewing, Motivation and Judgment, Journal of Medical Education 50:192-4, FEB 75 Haning WF, Prophylactic Iidocaine (LTR), JAMA 244(24): 2729, 19 DEC 80. Ditzler TF, Haning WF, A Comment on Alcoholism: A Problem for Women (LTR), Medical Self-Care NOV-DEC 89. Adams D. Ditzler T, Haning WF, Primary Caffeine Dependence: A Case Report, Hawaii Medical Journal 52(7):190- 4,JUL 93. Viola J, Ditzler TF, Kellar MA, Haning WF, Posttraumatic Stress Disorder and Sociopolitical Context: A Comment (LTR), Journal of Nervous and Mental Diseases 182(4), APR 94. Haning WF: Neuropsychological Complications of HIV Infection in Patients with Substance Use Disorders, chapter in ASAM monograph, Management of Patients with HIV Infection in Substance Abuse Treatment Facilities, M. Pohl (Ed.), May 1998 Haning WF: Chemical Dependence in the Multiethnic Society of Hawaii, Meeting Proceedings of the China Association for Mental Health, 12 Oct 1998; 1999, China Journal of Mental Health. Harai H, Murakami M, Haning WF, Anderson MP, Uchimura H: Comparison of Substance Use Disorder Treatment Between Hawaii and North Kyushu, Proceedings of the Ministry of Health Grants on Substance Abuse Research, March 2000; and Abstracts, American Society of Addiction Medicine 32nd Annual Medical-Scientific Conference, April 19-22, 2001, p. 143. Baker FM and Haning WF, Substance Abuse and Dependence in a Public Hospital: Hawaii, Hawaii Medical Journal 60(2): 35-38, Feb 2001. Haning WF: Giving Care to Impaired Providers, Hawaii Dental Journal Mar 2001 CERTIFICATION AND LICENSE(S) National Board of Medical Examiners 1976 Certified, ABPN, Adult Psychiatry 1998 Certified, ASAM 1991, Recertified 2000 Certified, ABPN, Addiction Psychiatry 1998 Hawaii